Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, POL, PSF

Long COVID Advocates Join Together To Form Alliance To Make Policy Recommendations, Secure Research Funding, And Transform Understanding Of Post-Viral Illnesses


LOS ANGELES, Feb. 25, 2021 /PRNewswire/ -- Today, leaders of 50 organizations and patient groups announced the formation of the Long COVID Alliance. The Alliance includes a network of patient-advocates, scientists, public health and disease experts, and drug developers who have joined together to leverage their collective knowledge and resources to educate policymakers and accelerate research that will address the challenges faced by 'COVID long haulers' and related post-viral illnesses.

Today, leaders of 50 organizations and patient groups announced the formation of the Long COVID Alliance.

Their goal is to transform the current understanding of Long COVID and related post-infectious illnesses such as:  myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS), other forms of dysautonomia, Ehlers-Danlos syndrome (EDS), hypermobility spectrum disorder (HSD) and mast cell activation syndrome (MCAS), autoimmune diseases and other related illnesses.

"The Long COVID Alliance is a critical collaboration based on the current reality that doctors and researchers are reporting that millions of COVID-19 patients continue to experience chronic and often debilitating post-viral symptoms. This state of extended illness is presently labeled Long COVID," said Oved Amitay, Solve M.E. President and Chief Executive Officer, one of the three Alliance founders. "Even though tests might reveal that no virus remains in the body, COVID-19 'long haulers' continue to struggle, often alone. Our community brings past experiences that are relevant to the current crisis."

In 2020, this same group came together to successfully call for urgent government investments for Long COVID, and $1.15 billion for long-term COVID-19 research at the National Institutes of Health shortly followed. The effort laid the foundation for the new Long COVID Alliance, which will prioritize:

"So many patients have bonded together as the healthcare community has not understood why some patients are asymptomatic and others are suffering moderate to debilitating issues a year later," said Hunter Howard, chairman of the Global Pandemic Coalition, a founder of the Alliance. "As one of the first infected in Texas, and a healthcare executive, I immediately noticed doctor friends did not understand my lingering symptoms or the novel coronavirus.  We started the Global Pandemic Coalition to bring together private companies to support the public sector pandemic initiatives.  If the vaccines continue to drive down mortalities, nothing may be more important now than coming together to drive understanding and fund research for the COVID survivors."

To accompany the Long COVID Alliance's launch, the initial partners from 2020 have drafted key recommendations and guidance for the National Institutes of Health (NIH), which can be found by visiting https://longcovidalliance.org/wp-content/uploads/2021/02/NIH-Long-COVID-Alliance-NIH-Recommendations-Letter-Final-with-signers.pdf 

Current Long COVID Alliance partners include:

"Many long haulers are now approaching a full year post-infection. We have lost jobs, lost significant quality of life, and lost pieces of who we once were. It's been a long road with an uncertain future and we've finally found hope," said Karyn Bishof, Founder of the COVID-19 Longhauler Advocacy Project and of the Long COVID Alliance. "With the help of our partners, we will ensure that Long haulers are not left out in the cold. The Long COVID Alliance will fight with us for awareness, answers, and ensuring that patient voices are included at every step of solving this 'second wave' Long COVID health crisis."

To learn more, join the Long COVID Alliance, or become a signatory to the NIH letter, visit: www.longcovidalliance.org.

About Solve M.E.
The Solve ME/CFS Initiative (Solve M.E.) is the leading, national non-profit organization solely dedicated to solving ME/CFS. We are committed to making ME/CFS understood, diagnosable, and treatable. Solve M.E. is the largest U.S. provider of private competitive research funding exclusively for ME/CFS working to accelerate the discovery of safe and effective treatments; we strive for an aggressive expansion of funding for research that will lead to a cure, and seek to engage the entire ME/CFS community.

Media Inquiries Only 
Contact Emily Taylor
Director of Advocacy and Communications
714-296-1661
[email protected]

ALL OTHER INQUIRIES, PLEASE CALL THE SOLVE ME/CFS INITIATIVE AT: 704-364-0016 OR EMAIL [email protected]

 

SOURCE Solve M.E.


These press releases may also interest you

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:00
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

9 mai 2024
Star Asia Group is pleased to announce that it has entered into a share transfer agreement with Minacia Co., Ltd. ("Minacia") on April 26, 2024, to acquire 100% of the shares of Minacia. 1? Reason for Share Acquisition Star Asia Group believes that...

9 mai 2024
In the Company's announcement dated May 9, 2024, the 2023 comparative year EBITDA was corrected from $33.2 million to $44.8 million. The complete correct press release follows: Q1 2024 Financial Highlights(1): Revenues of $602.5 millionGross Margin...

9 mai 2024
Afya Limited ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024)....

9 mai 2024
Source Energy Services Ltd. ("Source" or the "Company") is pleased to announce its financial results for the three months ended March 31, 2024. Q1 2024 PERFORMANCE HIGHLIGHTS Key achievements for the quarter ended March 31, 2024 include the...



News published on and distributed by: